Collaboration and Research Arrangements - Additional Information (Details) - USD ($) $ in Thousands		1 Months Ended		3 Months Ended
	Dec. 17, 2019	Jul. 31, 2023	Nov. 30, 2022	Mar. 31, 2023
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Revenue recognized				$ 2,954
Global Blood Therapeutics \| Collaboration Agreement
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Initial period of research term	3 years
Additional extension period for research term upon mutual agreement	1 year
Upfront payment receivable	$ 20,000
Additional extension period for research term			1 year
Reimbursements receivable of full-time employee and out-of-pocket costs and expenses	40,000
Revenue recognized				$ 3,000
Effective date of termination		Oct. 16, 2023
Milestone-based payment receivable	$ 0
Global Blood Therapeutics \| Collaboration Agreement \| Maximum
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Period of extension of initial research term	2 years